Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2003
09/25/2003WO2003078438A1 Carbamates as hiv protease inhibitors
09/25/2003WO2003078427A1 Azolylaminoazines as inhibitors of protein kinases
09/25/2003WO2003078426A1 Azolylaminoazine as inhibitors of protein kinases
09/25/2003WO2003078425A1 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt
09/25/2003WO2003078423A1 Compositions useful as inhibitors of protein kinases
09/25/2003WO2003078419A1 N-substituted benzothiophenesulfonamide derivative
09/25/2003WO2003078416A1 Therapeutic ion channel blocking agents and methods of use thereof
09/25/2003WO2003078413A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
09/25/2003WO2003078411A1 C3-cyano epothilone derivatives
09/25/2003WO2003078404A1 Pyrimidine derivatives
09/25/2003WO2003078398A1 NON-PEPTIDE GnRH ANTAGONISTS
09/25/2003WO2003078397A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
09/25/2003WO2003078394A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
09/25/2003WO2003077921A1 Azinylaminoazoles as inhibitors of protein kinases
09/25/2003WO2003077918A1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
09/25/2003WO2003077914A1 N3 alkylated benzimidazole derivatives as mek inhibitors
09/25/2003WO2003077910A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003WO2003077907A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003WO2003077903A1 C12-cyano epothilone derivatives
09/25/2003WO2003077828A2 Novel florfenicol-type antibiotics
09/25/2003WO2003077656A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
09/25/2003WO2003039451A3 Thiazole pyridazinones as adenosine antagonists
09/25/2003WO2002100818A3 Aminediols as agents for the treatment of alzheimer's disease
09/25/2003WO2002060392A3 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
09/25/2003US20030181499 For use as anti-human immunodeficiency virus (HIV) drugs
09/25/2003US20030181497 Heterocyclic acridone inhibitors of IMPDH enzyme
09/25/2003US20030181482 Antitumor agents, anticarcinogenic agents, a 3-oxoacetamideindolyl compounds, for treating cancer, cytotoxic, and angiogensis inhibitors
09/25/2003US20030181465 Pyrimidines as novel openers of potassium ion channels
09/25/2003US20030181460 Tertiary amines formed by reacting chemical intermediates such as 5-(4-fluorophenyl)-3-methyl-1,2,4-thiadiazole and 1-(3-(trifluoromethyl)phenyl)-piperazine, used for prophylaxis of vision defects and as tumor growth modulators
09/25/2003US20030181456 Heterocyclic amines used as antiemetics for prophylaxis of irritable bowel syndrome constipation, diarrhea, dyspepsia, nausea or vomiting
09/25/2003US20030181446 Novel N-acylated heterocycles
09/25/2003US20030181440 Isonipecotamides for the treatment of integrin-mediated disorders
09/25/2003US20030181420 Modulators of LXR
09/25/2003US20030181352 Substituted heterocyclic compounds
09/25/2003US20030180635 Visible radiation sensitive composition
09/25/2003CA2479481A1 Therapeutic ion channel blocking agents and methods of use thereof
09/25/2003CA2479266A1 Azetidine derivatives as ccr-3 receptor antagonists
09/25/2003CA2479069A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
09/25/2003CA2478731A1 Carbamates as hiv protease inhibitors
09/25/2003CA2478713A1 Non-peptide gnrh antagonists
09/25/2003CA2478653A1 Methods of treatment with selective ep4 receptor agonists
09/25/2003CA2478172A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
09/25/2003CA2478048A1 Novel florfenicol-type antibiotics
09/24/2003EP1346982A1 Vla-4 inhibitors
09/24/2003EP1345943A2 Inhibitors of papilloma virus
09/24/2003EP1345935A2 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345918A1 Chemical compounds
09/24/2003EP1345917A1 2-(2-(4-((2r)-2-methyl-3-(10h-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy)ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof
09/24/2003EP1345914A1 Therapeutic compounds
09/24/2003EP1345913A2 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
09/24/2003EP1345897A1 Chemical process and new intermediates
09/24/2003EP1345890A1 Glucagon antagonists/inverse agonists
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1345598A2 The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity
09/24/2003EP1242396B1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases
09/24/2003EP1178965B1 Quinoline derivatives as inhibitors of mek enzymes
09/24/2003EP1051415B1 Benzamide derivatives as vasopressin antagonists
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003CN1444584A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
09/24/2003CN1444583A Method for preparing arylacetyl aminothiazole
09/24/2003CN1444572A 2-aminothiazoline derivatives and their use as no-synthase inhibitors
09/24/2003CN1444569A Benzoxazole compound, process for producing the same and herbicide
09/24/2003CN1444567A 咪唑衍生物 Imidazole derivatives
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444481A Protease inhibitors
09/24/2003CN1444477A Thrombopoietin mimetics
09/24/2003CN1122039C Process for reducing prochiral ketone to produce optically active alcohol of high optical purity
09/24/2003CN1122022C Substituted oximes as neurokinin antagonists
09/24/2003CN1121859C Process for preparing pharmaceutical composition for treatment or prevention hypertension
09/23/2003USRE38257 Piperdine derivatives and hypotensives containing the same
09/23/2003US6624310 Epothilone minor constituents
09/23/2003US6624184 Amide and diamide inhibitors of IMPDH enzyme for use in treating IMPDH-associated disorders
09/23/2003US6624174 2-amino-nicotinamide derivatives and their use as VEGF-receptor tyrosine kinase inhibitors
09/23/2003US6624163 P-acylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2 -yl)-benzamides; treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, Parkinson's and Attention Deficit Hyperactivity Disorder
09/23/2003US6624157 Antitumor agents
09/23/2003US6624119 3-[Benz(ox/thi)azol-7-yl]-1h-pyrimidine-2,4-diones
09/23/2003CA2218555C Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
09/18/2003WO2003076437A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
09/18/2003WO2003076436A1 Derivatives of 4- (imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003WO2003076413A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
09/18/2003WO2003075924A1 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
09/18/2003WO2003075858A2 Bicyclic heterocycles for the treatment of diabetes and other diseases
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003048122A3 Inhibitors of cytosolic phospholipase a2
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003WO2002034745A8 Chemokine receptor binding heterocyclic compounds
09/18/2003US20030176701 Di-or triaza-spiro [4,5] decane derivatives
09/18/2003US20030176695 Such as N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-2-methyl-isonicotinamide for treatment of disorders of the central nervous system; neuroprotectants
09/18/2003US20030176642 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
09/18/2003US20030176487 For therapy and prophylaxis of disorders related to unregulated tyrosine kinase signal transduction, including cell proliferative and metabolic disorders
09/18/2003US20030176480 Amide-type triazole compounds
1 ... 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 ... 628